Marker Therapeutics, Inc. (MRKR)

2.19 +0.07 (+3.30%) USD  |  NASDAQ  |  Jan 21, 16:00
2.18 -0.01 (-0.46%) After-Hours: 20:00
More

Marker Therapeutics Total Expenses (TTM)

Total Expenses (TTM) Chart

View Total Expenses (TTM) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (TTM) Range, Past 5 Years

View Total Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (TTM) Benchmarks

View Total Expenses (TTM) Benchmarks
Start Trial
Viridian Therapeutics, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade